Page last updated: 2024-08-25

voriconazole and Communicable Diseases, Emerging

voriconazole has been researched along with Communicable Diseases, Emerging in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellesoeur, A; Blot, F; Chalumeau-Lemoine, L1
Amorim, A; Araujo, R; Oliveira, M; Sampaio-Maia, B1
Meenakshi, R; Ramakrishnan, R; Rameshkumar, G; Rathi, H; Venugopal, A1
Falzone, E; Guarneri, L; Gugliara, C; Maffeo, F; Pasqua, P; Pulvirenti, F1
Askari, E; Fernandez Guerrero, ML; Gadea, I; Prieto, E; Román, A1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G1
Jarque, I; Salavert, M1
Georgopoulos, A; Graninger, W; Kratzer, C; Schmoll, M; Tobudic, S1
Guarro, J; Pastor, FJ1

Reviews

3 review(s) available for voriconazole and Communicable Diseases, Emerging

ArticleYear
Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:7

    Topics: Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Voriconazole

2015
Emerging infectious endocarditis due to Scedosporium prolificans: a model of therapeutic complexity.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:11

    Topics: Adult; Amphotericin B; Antifungal Agents; Communicable Diseases, Emerging; Embolectomy; Endocarditis; Fatal Outcome; Female; Femoral Artery; Humans; Immunocompromised Host; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Scedosporium; Thrombosis; Tomography, X-Ray Computed; Triazoles; Voriconazole

2011
[The role of voriconazole in the treatment of emerging mycoses].
    Revista iberoamericana de micologia, 2007, Sep-30, Volume: 24, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Candidiasis; Communicable Diseases, Emerging; Fusarium; Humans; Mycoses; Opportunistic Infections; Paecilomyces; Pyrimidines; Scedosporium; Triazoles; Voriconazole

2007

Other Studies

6 other study(ies) available for voriconazole and Communicable Diseases, Emerging

ArticleYear
Excavated pneumonia: an unusual suspect.
    Intensive care medicine, 2013, Volume: 39, Issue:7

    Topics: Adult; Amphotericin B; Antifungal Agents; Azoles; Communicable Diseases, Emerging; Fatal Outcome; Febrile Neutropenia; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Pyrimidines; Respiratory Distress Syndrome; Tomography, X-Ray Computed; Triazoles; Voriconazole

2013
Fungal Keratitis Caused by Exserohilum, An Emerging Pathogen.
    Cornea, 2016, Volume: 35, Issue:5

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; Communicable Diseases, Emerging; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Male; Middle Aged; Mycoses; Natamycin; Ophthalmic Solutions; Retrospective Studies; Visual Acuity; Voriconazole; Young Adult

2016
[Rhodotorula glutinis sepsis. A case report].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Aged; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Communicable Diseases, Emerging; Comorbidity; Diabetes Complications; Fungemia; Humans; Immunocompromised Host; Liver Cirrhosis; Male; Mycoses; Pyrimidines; Rhodotorula; Sepsis; Triazoles; Voriconazole

2010
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole

2005
[Effect of new antifungals on the etiology of invasive fungal infections: emergence, resistance and breakthrough infection].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2006, Volume: 19, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Communicable Diseases, Emerging; Drug Resistance, Multiple, Fungal; Humans; Immunocompromised Host; Mycoses; Organ Transplantation; Postoperative Complications; Prosthesis-Related Infections; Pyrimidines; Recurrence; Triazoles; Voriconazole; Zygomycosis

2006
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Antimicrobial Cationic Peptides; Azoles; Chlorhexidine; Communicable Diseases, Emerging; Drug Synergism; Fluconazole; Guanidines; Humans; Microbial Sensitivity Tests; Mycoses; Polymers; Pyrimidines; Triazoles; Trichoderma; Voriconazole

2006